| User | Post |
|
9:39 am May 3, 2012
| Jae Jun
| | |
| Admin
| posts 1464 |
|
|
ok I see how you are thinking.
Great link by the way. I'm going to link to it in a post.
|
|
|
3:48 pm May 2, 2012
| nell
| | |
| Member | posts 103 |
|
|
Here is an example of the whole investing process from a value expert ..maybe it helps ;-)
http://www.hedgefundletters.co…..final1.pdf
|
|
|
3:36 pm May 2, 2012
| nell
| | |
| Member | posts 103 |
|
|
Just one last note.. A business model decides if a company is a longterm winner in my view ..Therefore this is for me priority 1 ;-)
|
|
|
3:26 pm May 2, 2012
| nell
| | |
| Member | posts 103 |
|
|
1. So when you go through stocks like this, how do you decide which one to buy?
2. Do you focus mainly on quants?
3. I ask because I see you provide a long list, but how do you decide which one to buy?
I thought Forbes provided an even bigger list.. 200 companies? ;-) I just filtered this list based on a residual income valuation model (p/iv < 0.6) Not perfect, but better than nothing ;-) So 15 companies survived this first round.. At this stage one can use different strategies..
1. Lazy approach -> Buy all, Small investments -> Idea: We dont know which companies will succeed, but we are sure that low valuations though imperfect will be corrected in time and winners will overshine some losers -> Risk: Valuation model imperfect, Estimates imperfect, Business risk, No due diligence etc.
2. Focus on bets with asymmetrical return profile -> Rank companies by return profile and buy highest ranked companies in different industries -> Approach: Concentrate on your best ideas, Minimize correlation and hope that at least one bet is super successful ;-)
3. Business approach -> Filter on business model factors (e.g. operating leverage, capital intensity, cash returns etc.) -> Combine this with 2. and hope that you picked winners ;-)
Whats your approach?? ;-)
|
|
|
10:55 am May 2, 2012
| Jae Jun
| | |
| Admin
| posts 1464 |
|
|
hey Nell,
So when you go through stocks like this, how do you decide which one to buy?
Do you focus mainly on quants?
I ask because I see you provide a long list, but how do you decide which one to buy?
|
|
|
8:43 am April 29, 2012
| nell
| | |
| Member | posts 103 |
|
|
@osage: Thanks for sharing your informations! Could you give some examples what kind of tickers are missing on finviz? Sounds great what medved quotetracker seems to offer.. I will check it out.. As a sidenote, you dont need to use an old pc as replacement when you switch to iMacs.. Parallels, virtualbox etc. allow you to use pc stuff on macs ;-)
Quick update..
| p/iv |
roi |
roe |
ticker |
price |
iv |
bv |
payout |
eps0 |
eps1 |
epsgrow |
| 0.19 |
0.53 |
0.17 |
rick |
9.21 |
47.8 |
8.23 |
0.0 |
1.2 |
1.4 |
0.4 |
| 0.21 |
0.5 |
0.13 |
glf |
47.24 |
221.08 |
37.85 |
0.0 |
3.26 |
4.95 |
0.5 |
| 0.69 |
0.18 |
0.15 |
prft |
12.34 |
17.79 |
6.92 |
0.0 |
0.94 |
1.05 |
0.2 |
| 0.58 |
0.22 |
0.17 |
tisi |
29.4 |
50.27 |
11.51 |
0.0 |
1.62 |
1.95 |
0.31 |
| 0.43 |
0.3 |
0.17 |
fele |
51.7 |
119.24 |
19.2 |
0.2 |
2.94 |
3.34 |
0.4 |
| 0.63 |
0.21 |
0.29 |
dxpe |
43.97 |
70.24 |
11.15 |
0.0 |
2.74 |
3.18 |
0.26 |
| 0.51 |
0.26 |
0.19 |
tess |
17.95 |
35.43 |
11.71 |
0.28 |
2.03 |
2.24 |
0.15 |
| 0.14 |
0.63 |
0.34 |
bry |
44.86 |
319.32 |
15.61 |
0.0 |
4.46 |
5.35 |
0.59 |
| 0.6 |
0.22 |
0.24 |
hwcc |
12.84 |
21.28 |
5.47 |
0.32 |
1.15 |
1.3 |
0.15 |
| 0.63 |
0.21 |
0.05 |
dgit |
9.41 |
14.96 |
18.67 |
0.0 |
0.67 |
0.9 |
0.14 |
| 0.68 |
0.19 |
0.33 |
med |
19.28 |
28.41 |
5.22 |
0.0 |
1.39 |
1.72 |
0.18 |
| 0.78 |
0.16 |
0.12 |
wwe |
7.91 |
10.14 |
3.97 |
2.18 |
0.4 |
0.47 |
0.1 |
| 0.72 |
0.18 |
0.27 |
ntri |
11.65 |
16.25 |
2.74 |
1.63 |
0.5 |
0.73 |
0.13 |
| 4.33 |
-0.18 |
0.03 |
rent |
18.61 |
4.3 |
4.84 |
0.0 |
-0.18 |
0.13 |
0.49 |
| 1.17 |
0.07 |
0.15 |
mtrx |
13.78 |
11.74 |
7.88 |
0.0 |
0.9 |
1.16 |
0.1 |
|
|
|
3:24 pm April 28, 2012
| osage100
| | Maine | |
| Member | posts 4 |
|
|
nell,
I use Finviz pretty extensively too. Trouble is I run across quite a few tickers that finviz doesn't have. I have also found a windows based program called "Medved QuoteTracker" that I think is superb. It is free if you have an account with TDAmeritrade (which I do) but, it is not expensive if you don't. It took me several weeks to get all the stocks in the NYSE into the program.
I switched to iMac for my next computer but, bought an old PC as a replacement just so I could still have access to Medved.
|
|
|
11:59 am March 3, 2012
| nell
| | |
| Member | posts 103 |
|
|
1. Market/Fundamental strength
I guess it is a combination with a good portion of a psychologic feedback loop. Most earnings reports were good. But as you can see DGIT was crushed. So even a big margin of safety couldnt prevent a 50% crash ;-)
2. Portfolio tracking
I use finviz for portfolio tracking and stock screening. It works quite nice and it offers a simple, free web interface.
Best wishes,
Nell
|
|
|
11:08 am March 3, 2012
| somrh
| | |
| Member | posts 336 |
|
|
That looks like finviz. (I just posted a link to their screener in the other thread. I haven't used that site for tracking portfolios though.)
Yahoo finance portfolios work pretty decent as well.
|
|
|
9:23 am March 3, 2012
| Jae Jun
| | |
| Admin
| posts 1464 |
|
|
i wonder how much of the increase has to do with the market going up vs actual fundamental strength.
What website do you use to manage and track your portfolio? Or is that your broker website?
I'm looking for one where i can have multiple portfolios to track. I'm using google at the moment and it barely meets my needs.
|
|
|
7:28 am March 3, 2012
| nell
| | |
| Member | posts 103 |
|
|
Quick update..
| p/iv |
roi |
roe |
ticker |
price |
iv |
bv |
payout |
eps0 |
eps1 |
epsgrow |
| 0.19 |
0.53 |
0.17 |
rick |
9.18 |
47.8 |
8.23 |
0.0 |
1.2 |
1.4 |
0.4 |
| 0.23 |
0.48 |
0.13 |
glf |
49.7 |
219.66 |
37.85 |
0.0 |
3.35 |
4.92 |
0.5 |
| 0.67 |
0.19 |
0.15 |
prft |
11.9 |
17.81 |
6.86 |
0.0 |
0.94 |
1.05 |
0.2 |
| 0.6 |
0.22 |
0.17 |
tisi |
29.93 |
49.82 |
11.2 |
0.0 |
1.68 |
1.93 |
0.31 |
| 0.41 |
0.31 |
0.17 |
fele |
50.47 |
123.15 |
19.9 |
0.2 |
2.92 |
3.45 |
0.4 |
| 0.62 |
0.21 |
0.27 |
dxpe |
38.82 |
62.11 |
10.42 |
0.0 |
2.45 |
2.82 |
0.26 |
| 0.54 |
0.25 |
0.18 |
tess |
17.98 |
33.5 |
11.71 |
0.28 |
2.01 |
2.13 |
0.15 |
| 0.33 |
0.37 |
0.34 |
bry |
53.02 |
159.96 |
15.45 |
0.0 |
4.21 |
5.31 |
0.35 |
| 0.67 |
0.19 |
0.23 |
hwcc |
14.05 |
20.93 |
5.45 |
0.32 |
1.18 |
1.28 |
0.15 |
| 0.69 |
0.19 |
0.05 |
dgit |
10.18 |
14.8 |
18.56 |
0.0 |
0.67 |
0.88 |
0.14 |
| 0.61 |
0.21 |
0.31 |
med |
16.19 |
26.35 |
5.11 |
0.0 |
1.43 |
1.6 |
0.18 |
| 0.63 |
0.21 |
0.16 |
wwe |
9.05 |
14.28 |
3.97 |
2.18 |
0.51 |
0.64 |
0.1 |
| 0.64 |
0.2 |
0.32 |
ntri |
11.2 |
17.45 |
2.91 |
0.97 |
0.46 |
0.92 |
0.13 |
| 4.67 |
-0.19 |
0.03 |
rent |
20.09 |
4.3 |
4.84 |
0.0 |
-0.16 |
0.13 |
0.49 |
| 1.1 |
0.08 |
0.15 |
mtrx |
12.95 |
11.74 |
7.88 |
0.0 |
0.91 |
1.16 |
0.1 |
|
|
|
11:49 am October 13, 2011
| nell
| | |
| Member | posts 103 |
|
|
quick valuation update of small list forbes best small companies as selected by my post from 2011/09/13:
|
p/iv
|
roi |
roe |
ticker |
price |
iv |
bv |
payout |
eps0 |
eps1 |
epsgrow |
| 0.21 |
0.5 |
0.14 |
rick |
7.77 |
36.75 |
7.81 |
0.0 |
0.96 |
1.09 |
0.4 |
| 0.24 |
0.46 |
0.1 |
glf |
42.93 |
177.82 |
37.61 |
0.0 |
1.85 |
3.85 |
0.51 |
| 0.29 |
0.41 |
0.14 |
prft |
8.82 |
30.78 |
6.7 |
0.0 |
0.8 |
0.97 |
0.38 |
| 0.37 |
0.34 |
0.17 |
tisi |
24.97 |
67.34 |
10.92 |
0.0 |
1.62 |
1.85 |
0.42 |
| 0.37 |
0.34 |
0.15 |
fele |
40.82 |
109.92 |
19.94 |
0.23 |
2.68 |
3.08 |
0.4 |
| 0.4 |
0.32 |
0.22 |
dxpe |
20.53 |
50.91 |
9.83 |
0.0 |
1.96 |
2.19 |
0.28 |
| 0.45 |
0.29 |
0.18 |
tess |
13.65 |
30.33 |
10.77 |
0.25 |
1.83 |
1.95 |
0.15 |
| 0.46 |
0.29 |
0.22 |
bry |
38.51 |
84.04 |
20.58 |
0.67 |
2.68 |
4.62 |
0.15 |
| 0.47 |
0.28 |
0.26 |
hwcc |
10.81 |
23.07 |
5.25 |
0.36 |
1.23 |
1.38 |
0.15 |
| 0.48 |
0.27 |
0.1 |
dgit |
18.6 |
38.59 |
18.48 |
0.0 |
1.5 |
1.91 |
0.26 |
| 0.5 |
0.27 |
0.36 |
med |
17.32 |
34.84 |
5.11 |
0.0 |
1.51 |
1.83 |
0.21 |
| 0.63 |
0.21 |
0.18 |
wwe |
9.93 |
15.67 |
4.23 |
2.0 |
0.61 |
0.78 |
0.08 |
| 0.67 |
0.19 |
0.37 |
ntri |
12.88 |
19.35 |
2.87 |
0.84 |
0.66 |
1.05 |
0.13 |
| 0.82 |
0.14 |
0.07 |
rent |
13.96 |
16.97 |
5.04 |
0.0 |
-0.05 |
0.35 |
0.54 |
| 0.91 |
0.12 |
0.15 |
mtrx |
10.23 |
11.23 |
7.54 |
0.0 |
0.89 |
1.11 |
0.1 |
|
|
|
11:35 am October 13, 2011
| nell
| | |
| Member | posts 103 |
|
|
Here is just a quick performance update of forbes 200 best small companies with p/iv < 0.6 ;-)
 
|
|
|
3:40 pm September 27, 2011
| Jae Jun
| | |
| Admin
| posts 1464 |
|
|
put up a short comment on CMTL on the C forum.
|
|
|
9:12 pm September 16, 2011
| ramboris
| | |
| New Member | posts 1 |
|
|
PETS is a company I've researched quite a bit. The major problem
with the company is its bad advertising. Management is buying the cheapest
possible time-slots to show their commercials. Nobody is going to see a
commercial at 11 or 12 in the morning on a Tuesday. That’s when everyone is
working or at school. The company also used to have Betty White as their
sponsor, however, she became too expensive and now they are using cartoons in
their commercials. The quality of their commercials is so bad that it’s
laughable. There is nothing wrong with trying to be more efficient and save the
company money. However, being cheap will hurt the company in the long run. I
don't know about you guys, but I'm staying away from this company.
There is one company that I do like,
I don’t know if it on that list or not. The ticker is MDF. Check it out!
Company Background
Metropolitan Health Networks, Inc.
(Metropolitan) operates a provider services network (PSN). The Company provides
and arranges for medical care to Medicare Advantage beneficiaries in the State
of Florida who have enrolled in health plans operated by Humana, Inc. (Humana),
or subsidiaries of Humana. Humana is one of the participants in the Medicare
Advantage program in the United States. As of December 31, 2009, the PSN
provided healthcare benefits to approximately 35,500 Medicare Advantage
beneficiaries. The Company also operated a health maintenance organization (the
HMO), which provided healthcare benefits to Medicare Advantage beneficiaries in
13 Florida counties. On August 29, 2008, the HMO was sold to Humana Medical
Plan, Inc. (the Humana Plan).
The company will close its acquisition
of CNU (competitor in same state) this month.
Based purely on a fundamental
analysis this company is outstanding. I'm sure you guys will see that after a
few minutes of research.
The reason I love this stock as a
long-term pick is this – Aging Baby Boomers! The state (Florida) where the
company's main base of operations is located is the second most popular state
for retirees, with the first being California. The Medicare eligible population
is projected to increase by 1.5 million by 2020. This means long term growth
for the company. Another thing I like about this company is its excellent management.
In fact, that’s the most important thing in any company as you all know.
There is one little problem that I
want you all to know. The company earns 99% of its revenues from Medicare. In
the short run that could make the company's cash flow more volatile. However,
in the long run I don't see it as a problem. Even if Medicare eventually gets
eliminated, I'm sure there will still be something else to help people pay for
their medical expenses.
To summarize my thoughts – Florida’s
aging population will grow at an exponential rate in the coming years. Old
people get sick, and where do they go? Well to Metropolitan Health Networks of
course!
This is just a quick analysis of the
company; I would be interested to see what you guys think.
I will also spend some time
analyzing that list to see if there are any hidden gems there.
|
|
|
6:38 pm September 14, 2011
| Jae Jun
| | |
| Admin
| posts 1464 |
|
|
yes after thinking about it more, it's a pass. No moat and sliding margins for 5 consecutive years is not a good indicator.
|
|
|
1:29 pm September 14, 2011
| nell
| | |
| Member | posts 103 |
|
|
My thoughts..
- no economic moat as everyone can set up a shop online
- high short interest
- declining sales and margins
In my view it is a pass..
—
TWST: How is the pet industry doing overall, and in particular how is PetMed Express doing?
Mr. Woo: The industry as a whole is doing really well. The pet industry continues to grow despite the economic recession that we've had. Within that, the pet medication area is also growing well. The nature of pet medication products is that it isn't discretionary for pet owners. It's not like buying some type of accessory. It is medication for the pet.
To give you a bit of a breakdown, the medicated pet business in the U.S. is about $3 billion. Approximately half of that is prescription and the other half is nonprescription. Just like with humans, some pet medications require a prescription from a doctor, a vet, and nonprescription medications are over the counter and don't require a prescription. The difference is that with human prescriptions you go to the doctor, you get the prescription and you go buy the prescription at a drug store; whereas, with pet medication you go to the vet, you get the prescription, and usually the vet dispenses the medication. So you usually can avoid having to go to a drug store.
As I said, the industry is doing really well, and people are making a lot of money in this business at every point of the chain. Everybody involved with pet medication, from the vets who sell the product to the manufacturers who are making the medication, is doing well. A lot of the positive growth has to do with growth rates for pets, as well as the fact that we are coming out of the really bad part of the economic recession. Within the pet business, however, there are subsets, and some of those are doing better than others.
PetMed Express, as a retailer, is having issues. The most important issue they are facing is competition, which is really affecting their business. Their most recently reported results showed about flat revenues with last year and declining earnings, and they have been having declining revenues and earnings relatively, consistently for the past year. It is such a profitable market that everybody is trying to compete with PetMed Express, particularly on the nonprescription side of the business. The reason people are looking even more at the nonprescription side is that it is relatively easy for people to get into that part of the business. Unlike the prescription side, you don't need a license to sell the product. You just need to set up a shop, get the supply and sell it. The bulk of that market is the flea and tick treatments, which all pet owners seem to use.
|
|
|
12:16 pm September 14, 2011
| Jae Jun
| | |
| Admin
| posts 1464 |
|
|
Post edited 5:17 am – September 14, 2011 by Jae Jun
PetMed Express (PETS)
Anyone have opinions or insight on PETS?
Quick notes as I was looking through the list.
Pet pharmacy. VERY strong balance sheet but latest year seeing difficult results. buying back a lot of shares and paying 5% dividend. Margins decreasing for 4 years and will be 5th year of decline = eroding moat. EBIT will likely be 12%.
Based on a back of the envelope valuation, conservative estimate is $14, normal range is $16.80 and aggressive valuation is $21.
Based on the numbers, the company is excellent, but if the decline in margins and margins continue, I'm worried that value will come down to meet price.
Thoughts?
|
|
|
4:37 pm September 13, 2011
| Jae Jun
| | |
| Admin
| posts 1464 |
|
|
great discussion. Good points by both.
Just a quick edit on my point regarding windows 8, it seems like windows 8 is for PC as well as mobile, just like how the current windows 7 is used for both PC and mobile as well.
So not being on windows 8 does affect their revenue, but to the point where it drops 30-40%? I'm not so sure about that.
However, I really do need to see some numbers before I add.
The valuation isn't exactly way below intrinsic value in my opinion. While it is cheap, it isn't screaming cheap.
|
|
|
3:54 pm September 13, 2011
| Jognils
| | |
| New Member | posts 2 |
|
|
@nell:
Thanks for the comments! I've found that I tend to downplay or ignore the negatives when I find a company that looks attractive, so I like having my positive points challenged and I agree with some of the risks you pointed out. That said, here are a few thoughts:
- PC licensing revenues represent 36% of total revenues ~ Quite a chunk of future sales and cashflow at risk
Just to clarify, PC is 36% of licensing revenues, 28% of total revenues, and Microsoft is only 12% of the 28% (FY10). So while it's a completely valid point, the revenue immediately at risk is only about a third of the figure you gave.
- Licensing multiple smaller entities will be less profitable (in contrast to pre Win8 times -> just Microsoft)
I would argue that while volume may drop, going back to contracts with individual OEMs and software vendors will actually be more profitable per unit than native inclusion in Windows. Microsoft was able to throw around its buyer power and pay Dolby significantly lower royalties than the 3rd parties with Windows Vista and 7. Here's an excerpt from the latest 10-K (p.42):
The inclusion of our technologies in Windows 7 Professional and Enterprise editions could result in our technologies residing in a greater percentage of PCs, though the benefit from this potential significant increase in reported units will be partially offset by substantial discounts, thereby reducing the average per unit royalty we would receive from Microsoft over time.
|
As a sidenote.. I would not argue with historical data points. Our world is changing, dolbys world is changing and we should value "future" cash flows! ;-)
An excellent point! Dolby has grown impressively since its IPO, but it's dangerous to project similar rates of growth into the future. It's stunning how quickly Dolby's sales mix has changed and continues to change based on consumer trends. This is a company and an industry where being nimble and responding quickly to market changes is absolutely crucial to stay competitive.
- brand reputation: would i pay more for dolby sound if i could get the same sound from a chinese supplier? im not sure if there is pricing power
Dolby wouldn't have become either the official or de facto coding standard in the majority of the markets it serves if it hadn't been able to differentiate itself and convince the leading players of the added value of its sound technologies. Chinese electronics manufacturers might be able to produce sound good enough to get by on low-end products (cheap DVD players, netbooks, etc.), but to my knowledge no competitor (domestic or foreign) has really been able to challenge Dolby's position simply by offering comparable sound at a lower price.
@Jae:
Thanks for the input! I'm thinking along the same lines, although I wasn't aware of the PC virtualization trend. Here's where I see future growth and future declines changing DLB's sales mix:
Growth:
- Online/streamed content and set-top boxes - As of the 2010 10-K, Apple, Amazon, Netflix, Omnifone, Rhapsody, Sonic, and Vudu all used Dolby technologies. That list has probably grown in the last three quarters.
- Mobile – on the Q3 call, management mentioned that mobile devices are the fastest growing market for Dolby and are approaching 10% of revenues, which, presumably, is when it would be disaggregated from "Other licensing" for reporting.
- Emerging markets penetration – Dolby has mostly saturated the U.S. market for its technologies in existing products (although new products will still provide growth opportunities), but BRIC and other countries have far lower attach rates and have been growing as a % of revenue
Decline:
- 3D and digital cinema – These markets still have some juice in them, but increasing competition and price pressures are squeezing out Dolby, which has about a 20% share of each market. Management estimated on the Q3 call that theaters are over halfway through the investment cycle for both technologies, so revenues will begin to taper off over the next year or two.
- PC – already discussed, but most likely a long-term net negative for sales
- DVD players – sales of standard-def players have been dropping for years and will continue to do so. Blu-ray growth is offsetting part of the decline, but I think online delivery to connected TVs will ultimately make DVDs nearly obsolete.
I'd love to hear any other thoughts you guys have!
|
|